Korean Post Marketing Surveillance To Observe Effectiveness And Safety Of Pristiq (Registered) In Patients With Major Depressive Disorder.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2017
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- Acronyms PMS
- Sponsors Pfizer
- 11 May 2016 Status changed from not yet recruiting to recruiting.
- 07 Mar 2016 Planned initiation date changed from 1 Apr 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.
- 11 Dec 2015 Planned initiation date changed from 1 Dec 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.